A method of treating a cancer in a subject is disclosed comprising administering to the subject an immunomodulator and a second therapeutic agent wherein: (i) the immunomodulator is chosen from one or more of: an activator of a costimulatory molecule or an inhibitor of an immune checkpoint molecule and (ii) the second therapeutic agent is LDK378 thereby treating the cancer..